The EU decision should be delayed at least until the next meeting as new negative information about Kynmaro can be factored in to make it overwhelming for AEGR to be approved.
An earlier EU decision is better. It will happen next week.
Then watch the shorts whine about more manipulation as the potential patient population triples.
Depends on how bad the information is about Kynmaro. Right now, it looks like AEGR is on track for approval already by the EMA.